Repligen | RGEN - Interest Income


Repligen reported $7.31M in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Agilent USD 13M 2M Mar/2026
Align Technology USD 3.91M 710K Mar/2026
Bio Techne USD 981K 84K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Bruker USD 15.3M 10.9M Jun/2026
Charles River Laboratories USD -0.03 0.27 Jun/2026
Danaher USD 1.23 27M Jun/2026
Dentsply International USD 4M 1000K Mar/2025
General Electric Aerospace USD 450M 288M Dec/2025
Henry Schein USD 0.82 0.1 Jun/2026
Illumina USD 1.35 0.48 Jun/2026
IQVIA Holdings USD 7M 3M Jun/2026
Myriad Genetics USD 300K 0 Mar/2025
Pfizer USD -0.04 115M Jun/2026
Repligen USD 7.31M 979K Mar/2025
Revvity USD 6.3M 552K Mar/2026
Standard Biotools USD 3.51M 1.37M Mar/2026
Thermo Fisher Scientific USD 233M 25M Mar/2026
Waters USD 6M 331K Mar/2026
West Pharmaceutical Services USD 5.1M 0 Mar/2026